The Drugs Controller General of India has approved the commercial launch of "Feluda", the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of...
from NDTV News - Topstories https://ift.tt/2FMnI1j
Subscribe to:
Post Comments (Atom)
'Extra payout' to Maharashtra PSU: HDFC board slaps Rs 1 lakh fines on MD, CFO
HDFC Bank's board penalized top executives over deposit arrangements with MSRDC. The internal review found business overreach but no per...
-
China has emerged as a significant player in AI foundation models with DeepSeek, creating powerful AI models at lower costs than the West. T...
-
The buzz in Telangana is that Chief Minister K Chandrashekar Rao, who has ambitions of a role in national politics, could resign in favour o...
-
Nigeria's President Buhari on Sunday denied claims that he had died and been replaced by a Sudanese impostor, breaking his silence on a ...
No comments:
Post a Comment